## **Core Concept**
The question tests the interaction between antibacterials and neuromuscular blocking agents, specifically **d-tubocurarine**, a non-depolarizing neuromuscular blocker. The key concept here involves understanding how certain antibiotics can potentiate neuromuscular blockade.

## **Why the Correct Answer is Right**
The correct answer, **D. Aminoglycosides**, is right because **aminoglycoside antibiotics** can potentiate neuromuscular blockade when used with **d-tubocurarine**. Aminoglycosides interfere with calcium ion entry at the nerve terminal, reducing acetylcholine release, which can enhance the neuromuscular blocking effect of **d-tubocurarine**. This can lead to increased muscle weakness or paralysis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because **β-lactam antibiotics** (like penicillins and cephalosporins) do not typically potentiate neuromuscular blockade to a significant extent and are not generally contraindicated with **d-tubocurarine**.
- **Option B:** This option is incorrect because **macrolides** (like erythromycin) do not have significant interactions with neuromuscular blockers like **d-tubocurarine**.
- **Option C:** This option is incorrect because **quinolones** do not have well-documented interactions that would contraindicate their use with **d-tubocurarine** in terms of neuromuscular blockade potentiation.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that certain classes of antibiotics, notably **aminoglycosides**, can enhance the effects of non-depolarizing neuromuscular blockers. This is crucial in clinical settings, especially in intensive care units or during surgeries where neuromuscular blockers are used.

## **Correct Answer:** . Aminoglycosides